As a long-time tech-investing analyst, I have one of the best vantage points in the country for tracking profitable marijuana industry trends.
Here's the thing: I live 10 minutes from the epicenter of the medical marijuana movement in northern California, and the rest of the nation for that matter.
Downtown Oakland contains a small cannabis-friendly district known as "Oaksterdam." In fact, there's a patient co-op across the street from a store where I buy my fedoras.
I bring all this up so you know I've followed what's been happening with the marijuana legalization movement for years.
In these parts, it's difficult to avoid – you see lots of folks walking around wearing their official Oaksterdam t-shirts.
Since California legalized medical marijuana in 1996, another 19 states have joined the movement.
The San Francisco-based market research firm ArcView Group estimates the national legal marijuana market at $1.53 billion in 2013. ArcView expects sales to nearly double to $2.57 billion by the end of this year.
Clearly, the industry is growing rapidly, and there's big money to be made… especially if you hear about its best profit play…
Avoid the New Industry Hype, and Take Profits
In a moment, I will tell you about what I think is by far the best cannabis tech play available today.
It involves a highly respected biotech firm with truly great science that has used a series of compounds known as cannabinoids to create breakthrough drugs to treat everything from pain to epilepsy to schizophrenia.
Before I do that, I want to give you some context to measure it against by taking a moment to analyze what have become highly popular marijuana stocks.
As I see it, these investments have received way too much hype. Yes, in the long run the industry will do well.
But right now, the stocks getting the most attention are traded over the counter. I generally only recommend OTC stocks of foreign firms that are co-listed on a major exchange and where I can quickly get detailed financial data.
While some of these OTC cannabis shares define penny stocks, a couple of them are starting to get pricey. Take a look:
- Cannabis Science, Inc. (OTC: CBIS) is involved in the research and development of cannabinoid-based therapies for the treatment of HIV/AIDS and cancer. With a market cap of $144 million, the stock trades at $0.18.
- Medical Marijuana, Inc. (OTC: MJNA) was the first publicly traded company venturing into medical marijuana and industrial hemp farming. It has a market cap of $303 and trades at $0.30.
- Vape Holdings, Inc. (OTC: VAPE) is a relatively young company specializing in vaporizers, e-cigarettes, and cannabis concentrates. E-cigarette sales eclipsed $1 billion in 2013, and cannabis concentrates have the highest growth segment in the industry. It has a market cap of $209 million and trades at $24.40.
- Medbox, Inc. (OTC: MDBX) makes and operates vending machines that dispense pharmaceuticals, primarily cannabis-based products, and has several patents in the field. MDBX has a market cap of $440 million and trades at $28.50.
- CannaVEST Corp. (OTC: CANV) is a producer of hemp- and cannabis-based products, particularly those with cannabidiol, a non-intoxicating extract. With a market cap of $810 million, the stock trades at $68.
As intriguing as these cannabis stocks may be, we actually have a much smarter play for you…
Join the conversation. Click here to jump to comments…
About the Author
Michael A. Robinson is one of the top financial analysts working today. His book "Overdrawn: The Bailout of American Savings" was a prescient look at the anatomy of the nation's S&L crisis, long before the word "bailout" became part of our daily lexicon. He's a Pulitzer Prize-nominated writer and reporter, lauded by the Columbia Journalism Review for his aggressive style. His 30-year track record as a leading tech analyst has garnered him rave reviews, too. Today he is the editor of the monthly tech investing newsletter Nova-X Report as well as Radical Technology Profits, where he covers truly radical technologies – ones that have the power to sweep across the globe and change the very fabric of our lives – and profit opportunities they give rise to. He also explores "what's next" in the tech investing world at Strategic Tech Investor.
Sounds very interesting. Are Leaps available? Does the estimated timetable fit in with that kind of strategy. If I can buy Jan 16 leaps, do I have enough time?
Amf
I am I interested in investing some money in gw Pharmaceuticals plc. I only have $2000 to invest right now. Who do I contact
It dropped over 8% today, kevin. Just be glad you didn't know whom to contact.
DEAR MR ROBINSON
PLEASE COMMENT ON ALNY,INVN,APPL,BUY,HOLD OR SELL
IF YOU ONLY HAVE ONE STOCK TO BUY TODAY PLAESE TELL ME YOUR PICK IHAVE ONLY TEN THOUSAND DOLLARS TO INVEST.THANK YOU .I APPRECIATE YOUR KNOWLEDGE AND EXPERTIES.
I AM ALREADY A SUSCRIBER